From 5e20003f939d97889a285b3bfcdbb6f12a423e66 Mon Sep 17 00:00:00 2001 From: OpenWiki Bot Date: Mon, 27 Jul 2026 02:21:48 +0800 Subject: [PATCH] chore: daily update 2026-07-27 --- .last-update.json | 2 +- commitments.md | 7 +++- quickstart.md | 2 +- sources/git-repo.md | 9 +++-- sources/hackernews.md | 80 ++++++++++++++++++++++++++----------------- sources/web-search.md | 73 +++++++++++++++++++++++++++++++++++++++ themes.md | 3 +- 7 files changed, 138 insertions(+), 38 deletions(-) diff --git a/.last-update.json b/.last-update.json index a2a9cf4..409a6af 100644 --- a/.last-update.json +++ b/.last-update.json @@ -1,5 +1,5 @@ { - "updatedAt": "2026-07-26T17:31:08.313Z", + "updatedAt": "2026-07-26T18:21:48.752Z", "command": "update", "model": "MiniMax-M3" } diff --git a/commitments.md b/commitments.md index bdcea45..d2bb71a 100644 --- a/commitments.md +++ b/commitments.md @@ -4,7 +4,12 @@ Concrete work tasks, follow-ups, approvals, and scheduled items extracted from G ## Active -_No active commitments yet._ +### china-cde-cell-gene-therapy-rules-2026: verify CDE classification scope for Chinese pharma / CDMO conversations +- Owner: me +- Source: web-search — cisema.com 2026-07-24 (China CDE Defines Classification Rules for Cell & Gene Therapy Drugs) +- Due: unscheduled +- Status: open +- Notes: Single credible regulatory-trade source. Pull the NMPA/CDE-direct release before the next vendor sync; check whether any active CellShot-TriArm or ClinoReactor-class deals depend on the new classification scope.